Literature DB >> 15859160

Establishment and characterization of a new human glioblastoma cell line, NYGM.

Yoshitsugu Nuki1, Shunro Uchinokura, Shiro Miyata, Tsuyoshi Fukushima, Ryouichi Hamasuna, Shinichi Nakano, Shinichiro Wakisaka, Yutaka Akiyama, Hiroshi Itoh, Hiroaki Kataoka.   

Abstract

A cell line designated NYGM was established from a human cerebral glioblastoma multiforme (GBM) obtained from a 75-year-old Japanese woman. The cell line has grown slowly without interruption and has been propagated continuously by serial passages (more than 80 passage) during the past 3 years. The cultured cells were fusiform or polyhedral in shape. The population doubling time was 24 hours. The chromosomal number varied between 77 and 88, with modal chromosomal number of 84. NYGM cells concomitantly expressed MET receptor tyrosine kinase (a product of c-met protooncogene) and its ligand HGF/SF (hepatocyte growth factor/scatter factor), as well as HGF activator and HGF activator inhibitors. The cells might be useful for the study of pericellular regulation of HGF/SF-MET signaling and HGF activation of GBM cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15859160     DOI: 10.1111/j.1749-0774.2004.tb00031.x

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  23 in total

Review 1.  Scatter-factor and semaphorin receptors: cell signalling for invasive growth.

Authors:  Livio Trusolino; Paolo M Comoglio
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

Review 2.  Cellular mechanisms targeted during astrocytoma progression.

Authors:  V Peter Collins
Journal:  Cancer Lett       Date:  2002-12-15       Impact factor: 8.679

3.  Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.

Authors:  R Abounader; S Ranganathan; B Lal; K Fielding; A Book; H Dietz; P Burger; J Laterra
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

4.  Purification and subunit structure of hepatocyte growth factor from rat platelets.

Authors:  T Nakamura; K Nawa; A Ichihara; N Kaise; T Nishino
Journal:  FEBS Lett       Date:  1987-11-30       Impact factor: 4.124

5.  Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.

Authors:  H Kataoka; R Hamasuna; H Itoh; N Kitamura; M Koono
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

6.  Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans.

Authors:  T Moriyama; H Kataoka; H Kawano; K Yokogami; S Nakano; T Goya; H Uchino; M Koono; S Wakisaka
Journal:  Cancer Lett       Date:  1998-02-27       Impact factor: 8.679

7.  Long-term glioblastoma multiforme survivors: a population-based study.

Authors:  J N Scott; N B Rewcastle; P M Brasher; D Fulton; N A Hagen; J A MacKinnon; G Sutherland; J G Cairncross; P Forsyth
Journal:  Can J Neurol Sci       Date:  1998-08       Impact factor: 2.104

Review 8.  Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor.

Authors:  Hiroaki Kataoka; Shiro Miyata; Shunro Uchinokura; Hiroshi Itoh
Journal:  Cancer Metastasis Rev       Date:  2003 Jun-Sep       Impact factor: 9.264

9.  Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer.

Authors:  D Naka; T Ishii; Y Yoshiyama; K Miyazawa; H Hara; T Hishida; N Kidamura
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

10.  Radiosurgery as part of the initial management of patients with malignant gliomas.

Authors:  J S Loeffler; E Alexander; W M Shea; P Y Wen; H A Fine; H M Kooy; P M Black
Journal:  J Clin Oncol       Date:  1992-09       Impact factor: 44.544

View more
  4 in total

1.  Establishment and characterization of human glioblastoma cell line (HUBT-n).

Authors:  Isamu Ishiwata; Chieko Ishiwata; Emiko Ishiwata; Megumi Iguchi; Yoshiro Sato; Makoto Sonobe; Kazushige Kiguchi; Toshiaki Tachibana; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2005-03       Impact factor: 4.174

2.  Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-κB, on glioblastoma.

Authors:  Tsuyoshi Fukushima; Makiko Kawaguchi; Kenji Yorita; Hiroyuki Tanaka; Hideo Takeshima; Kazuo Umezawa; Hiroaki Kataoka
Journal:  Neuro Oncol       Date:  2011-10-03       Impact factor: 12.300

3.  Roles of Kunitz domains in the anti-invasive effect of hepatocyte growth factor activator inhibitor type 1 in human glioblastoma cells.

Authors:  Shiro Miyata; Tsuyoshi Fukushima; Kazuyo Kohama; Hiroyuki Tanaka; Hideo Takeshima; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2007-11       Impact factor: 4.174

4.  Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas.

Authors:  Tsuyoshi Fukushima; Makiko Kawaguchi; Koji Yamamoto; Fumiki Yamashita; Aya Izumi; Takashi Kaieda; Yuka Takezaki; Hiroshi Itoh; Hideo Takeshima; Hiroaki Kataoka
Journal:  Cancer Sci       Date:  2018-08-16       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.